(NASDAQ: SNY) Sanofi's forecast annual revenue growth rate of 8.05% is forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 7.27%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.4%.
Sanofi's revenue in 2025 is $46,131,250,000.On average, 5 Wall Street analysts forecast SNY's revenue for 2025 to be $63,928,985,265,580, with the lowest SNY revenue forecast at $60,607,167,030,249, and the highest SNY revenue forecast at $68,400,179,494,640. On average, 5 Wall Street analysts forecast SNY's revenue for 2026 to be $68,749,857,336,230, with the lowest SNY revenue forecast at $63,927,158,790,126, and the highest SNY revenue forecast at $74,921,240,010,210.
In 2027, SNY is forecast to generate $73,503,473,174,478 in revenue, with the lowest revenue forecast at $69,722,277,415,483 and the highest revenue forecast at $78,997,640,180,330.